Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer.
about
Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma.Mutated Chromatin Regulatory Factors as Tumor Drivers in CancerRole of ARPC2 in Human Gastric Cancer.Curcumin Inhibits LIN-28A through the Activation of miRNA-98 in the Lung Cancer Cell Line A549.EZH2 inhibitors: a patent review (2014-2016).Developing EZH2-Targeted Therapy for Lung Cancer.Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2.Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2.CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2.A new transgenic mouse model for conditional overexpression of the Polycomb Group protein EZH2.In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis.ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer.Transcriptional deregulation underlying the pathogenesis of small cell lung cancer.Patient derived organoids to model rare prostate cancer phenotypes.
P2860
Q33717790-5A90D989-F137-4140-9178-440A54E75F07Q37592666-13484276-7A31-408F-AD0F-D4520103C75FQ38697602-90CA4E91-F37A-4696-AFF2-517D89B943D5Q38701115-7A95C822-7E74-4BD6-A87B-124202385A31Q38844652-D718E52D-4882-4E0D-9BC6-C09EBD7BEC0FQ41021134-D32A0129-2B76-4085-8617-45288DD75429Q41819380-324EB870-0A14-4770-A985-E2191AA1F1FBQ42687340-A41950ED-409F-45EF-B2C0-83FB91759655Q46167320-5CA940D9-15FE-4798-9E6B-9199EFEF8E91Q51347999-18445FB4-CD01-45BA-8E53-53A038A36044Q52431419-FE59412B-32E0-43C4-8066-B46DD01C9FF5Q52718548-8410A4A9-E7CB-4D5C-A57B-780161527D12Q55011897-B117FE71-CE88-4835-9054-7CF35CBD1E2EQ55367999-904BAA40-06C1-4D79-9BA5-851D4610E216
P2860
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer.
@en
type
label
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer.
@en
prefLabel
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer.
@en
P2093
P2860
P50
P1433
P1476
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer
@en
P2093
Carla F Kim
Charles Y Lin
Eiki Kikuchi
Grit S Herter-Sprie
Haikuo Zhang
Henry Long
Hideo Watanabe
Jacob B Reibel
Jaime M Reyes
P2860
P304
P356
10.1158/2159-8290.CD-16-0164
P577
2016-06-16T00:00:00Z